If you hold a New York or New Jersey cannabis license, much of what it is worth has nothing to do with how much cannabis you sell. It comes from how hard it is for anyone else to get one. A petition docketed at the Supreme Court this month asks whether states may keep it that hard by favoring their own residents. The Court has not agreed to hear the case and may never. But the question is not going away, and the market will price the answer into your license long before any decision issues.
What the petition asks, and what it does not
The dormant Commerce Clause is the constitutional rule that a state may not write its economic laws to favor its own residents over people from other states.
Applied to cannabis, it has split the federal appeals courts. The First Circuit applied it to Maine’s medical market in Northeast Patients Group in 2022,[1] and the Second Circuit to New York’s adult-use licensing in Variscite in 2025.[2] In January, the Ninth Circuit went the other way in Peridot Tree, holding that the rule does not protect a market Congress has made illegal.[3] The Peridot Tree plaintiffs now ask the Supreme Court to resolve the conflict.
Note what the rule does not reach. It polices discrimination, not scarcity. It says nothing about how many licenses a state may issue and a great deal about who may hold them.
Note, too, the odds. The Court turned away a related Maryland petition earlier this year and has generally avoided these federal-state conflicts. Treat this as a risk to plan around, not an event to predict.
What is exposed in New Jersey and New York
New Jersey’s rule is the conventional kind. CREAMMA requires every license application to include at least one significantly involved person who has lived in New Jersey for at least two years; five years earns a ranking preference.[4] Microbusinesses must be wholly owned by two-year residents, with a majority of owners, officers, or employees living in or next to the host municipality.
New York’s is more instructive, because the rule struck down in Variscite never mentioned residency. It gave “extra priority” to applicants with pre-2021 marijuana convictions under New York law. An identical conviction from another state earned nothing. The court called that protectionism.
The lesson reaches past residency clauses. A criterion need not say “you must live here” to be vulnerable. It is enough that in-state status decides the outcome.
Rhode Island shows what the risk looks like
Rhode Island capped adult-use retail at 24 licenses and required majority in-state ownership. Three out-of-state applicants sued in Jensen, Kenney, and Palmore.[5] The district court initially dismissed two of the cases as premature; the First Circuit reversed and ordered a prompt ruling on the merits.[6] On remand in April 2026, the court blocked the residency and social equity provisions and halted the licensing round outright: no lottery, and no processing of any pending application.
The court rejected every justification the state offered. Whether an out-of-stater owns 49, 51, or 100 percent of a dispensary, it reasoned, has nothing to do with the regulator’s power to oversee it. Nor could the state credit only Rhode Island Convictions and the neighborhoods; one plaintiff’s cannabis conviction and distressed neighborhood were in Los Angeles, and neither counted. The court then went further, finding the social equity criteria likely irrational under the Equal Protection Clause, because most of them measured poverty and unemployment rather than any harm from cannabis enforcement.
Ninety-eight applicants had paid fees, signed leases, and spent real money. None was a party. The court acknowledged their reliance and halted the round anyway, calling the fallout self-inflicted because the state pressed ahead while the challenge was pending.
That is the exposure worth planning for. Not that a competitor from Colorado opens down the street in 2029, but that the criteria under which your license issued, or your application is pending, becomes the subject of an injunction while you are holding a lease.
What would change, and what would not
Suppose the challengers ultimately win. License caps survive. So do municipal opt-outs, zoning and buffer rules, ownership limits, and neutral capital requirements, because each applies equally to residents and nonresidents. Scarcity survives. What changes is who may own, fund, and buy the scarce asset.
Even that change may be smaller than it sounds. Outside capital is already here, through management services agreements, brand licensing, real estate and equipment leases, and debt with warrants or conversion rights. A ruling for the challengers would mostly lower the cost of those structures, not open a closed door.
States will try to preserve their preferences by recasting them. Rhode Island suggests that path is narrower than it looks. A geographic preference that credits only in-state distressed areas repeats the Variscite defect. A preference keyed to poverty rather than cannabis enforcement invites the equal protection attack. New Jersey’s impact zone framework, which counts only New Jersey municipalities, sits squarely in the line of fire.
Four things to do now
- Audit which of your qualifying criteria turn on in-state status, including impact zone and social equity credits. A buyer’s counsel will look there first.
- Expect the question in diligence. Acquirers and lenders will want to know whether your license issued under challengeable criteria, and the answer can move price whether or not any court rules.
- If you have an application pending, know what happens to your fees, your lease, and your place in line if the round is halted.
- Revisit capital structures built around residency rules. If the rules fall, the workaround may become unnecessary, expensive, or both. Your agreements should anticipate that.
The larger point
The industry has spent years treating interstate commerce as the transformational event. Interstate shipment is still years away. The opening of ownership, investment, and acquisition could come much sooner, and it will show up in what licenses trade for long before any court says a word.
[1] Northeast Patients Group v. United Cannabis Patients & Caregivers of Maine, 45 F.4th 542 (1st Cir. 2022).
[2] Variscite NY Four, LLC v. New York State Cannabis Control Board, 152 F.4th 47 (2d Cir. 2025).
[3] Peridot Tree WA, Inc. v. Washington State Liquor and Cannabis Board, 162 F.4th 1179 (9th Cir. 2026), petition for cert. filed, No. 26-343 (U.S. Sept. 2026).
[4] New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, N.J.S.A. 24:6I-36; N.J.A.C. 17:30-7.10, 17:30-7.11.
[5] Jensen v. Rhode Island Cannabis Control Commission, No. 1:24-cv-00191-MRD-AEM; Kenney v. Rhode Island Cannabis Control Commission, No. 1:24-cv-00252-MRD-AEM; Palmore v. Rhode Island Cannabis Control Commission, No. 1:25-cv-00622-MRD-AEM (D.R.I. Apr. 8, 2026) (memorandum and order granting preliminary injunction and denying motions to dismiss).
[6] Jensen v. Rhode Island Cannabis Control Commission, 160 F.4th 18 (1st Cir. 2025) (No. 25-1132); Kenney v. Rhode Island Cannabis Control Commission, 160 F.4th 211 (1st Cir. 2025) (No. 25-1173).